Vol. 24 No. 2 (2022): Oncology

View Vol. 24 No. 2 (2022): Oncology

DOI: https://doi.org/10.32471/oncology.2663-7928.t-24-2-2022-g

Published: 2026-01-13

Editorial

SYMBIOSIS OF MEDICAL TECHNOLOGIES AND ARTIFICIAL INTELLIGENCE: IMPULSE OF NEW OPPORTUNITIES IN ONCOLOGY

V.F. Chekhun

65-67
- PDF (Українська)

Review

COVID-19 AND CANCER: SCIENTIFIC AND CLINICAL ASPECTS

L.A. Naleskina , N.Y. Lukianova , L.M. Kunska, V.F. Chekhun

68-78
- PDF (Українська)
DOI: https://doi.org/10.32471/oncology.2663-7928.t-24-2-2022-g.10627

Original investigations

THE EFFECT OF ACTIVATION OF TOLL-LIKE RECEPTORS ON THE CD150 EXPRESSION LEVEL IN MALIGNANT B-LYMPHOCYTES OF PATIENTS WITH CHRONIC LYMPHOCYTIC LEUKEMIA

V.M. Shcherbina, I.M. Gordiienko

79-86
- PDF (Українська)
DOI: https://doi.org/10.32471/oncology.2663-7928.t-24-2-2022-g.10526
miRNA EXPRESSION PROFILE ASSOCIATED WITH AGGRESSIVENESS OF BREAST CANCER OF DIFFERENT MOLECULAR SUBTYPES

T.V. Borikun, V.M. Bazas, T.V. Zadvornyi, Н.Ю. Лук’янова

87-96
- PDF (Українська)
DOI: https://doi.org/10.32471/oncology.2663-7928.t-24-2-2022-g.10453
SIGNIFICANCE Of KI-67 EXPRESSION FOR PREDICTING The COURSE OF LOCALLY DIFFUSED HORMONE- DEPENDENT BREAST CANCER

O.S. Pridko, M.F. Rishko, A.V. Rusyn

97-101
- PDF (Українська)
DOI: https://doi.org/10.32471/oncology.2663-7928.t-24-2-2022-g.10608
TUMOR MICROENVIRONMENT AND BODY MASS INDEX IN GASTRIC CANCER PATIENTS: FORMATION OF GROUPS AT RISK OF ADVERSE COURSE

I.I. Ganusevich, L.M. Bubnovska , A.I. Goncharenko , A.P. Burlaka

102-108
- PDF (Українська)
DOI: https://doi.org/10.32471/oncology.2663-7928.t-24-2-2022-g.10456
THE RATIO OF CD-68+ AND CD-163+ MACROPHAGES IN ENDOMETRIAL ENDOMETRIOID CARCINOMA

I.P. Nesina , N.P. Iurchenko , O.M. Movchan, N.M. Glushchenko , L.G. Buchynska

109-113
- PDF (Українська)
DOI: https://doi.org/10.32471/oncology.2663-7928.t-24-2-2022-g.10575
THE ASSESSMENT OF THE EFFICIENCY OF ALPHA-LIPOIC ACID AND IPIDACRINE HYDROCHLORIDE TREATMENT IN THE PREVENTION OF PACLITAXEL-INDUCED PERIPHERAL NEUROPATHY BASED ON THE PATIENT NEUROTOXICITY QUESTIONNAIRE

S.I. Golotyuk, I.S. Golotyuk

114-120
- PDF (Українська)
DOI: https://doi.org/10.32471/oncology.2663-7928.t-24-2-2022-g.10522

Opinion

EVALUATION OF OBJECTS OF INTELLECTUAL PROPERTY RIGHTS IN THE MEDICAL AND BIOLOGICAL FIELD AS A STAGE OF THEIR COMMERCIALIZATION

T. Pyatchanina , A. Ogorodnyk, O. Dvorshchenko

121-124
- PDF (Українська)
DOI: https://doi.org/10.32471/oncology.2663-7928.t-24-2-2022-g.10540